BioCentury
ARTICLE | Company News

GSK restructuring European business

February 7, 2013 2:09 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) CEO Andrew Witty said the pharma will restructure its European pharmaceuticals business because of a "sustained shift we have witnessed in the European reimburs...